| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 64.35M | -68.31M | 30.75M | -39.79M | 18.69M | 78.54M |
| Gross Profit | 20.00M | -68.31M | 14.10M | -51.91M | 3.68M | 78.54M |
| EBITDA | -74.69M | -143.16M | 3.79M | 0.00 | -1.94M | 0.00 |
| Net Income | -93.58M | -143.16M | 3.79M | -56.02M | 8.84M | 53.16M |
Balance Sheet | ||||||
| Total Assets | 1.03B | 1.06B | 1.25B | 1.27B | 1.33B | 1.34B |
| Cash, Cash Equivalents and Short-Term Investments | 213.00K | 1.11M | 261.00K | 11.00K | 276.00K | 14.00K |
| Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 13.77M | 11.79M | 12.22M | 13.76M | 23.55M | 38.12M |
| Stockholders Equity | 1.02B | 1.05B | 1.24B | 1.25B | 1.31B | 1.30B |
Cash Flow | ||||||
| Free Cash Flow | 5.88M | 0.00 | 20.47M | -265.00K | 262.00K | -3.00K |
| Operating Cash Flow | 30.03M | 43.91M | 20.47M | -265.00K | 262.00K | -3.00K |
| Investing Cash Flow | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financing Cash Flow | -30.38M | -43.06M | -20.22M | 0.00 | 0.00 | 0.00 |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | £1.76B | ― | 2.24% | 2.40% | 64.34% | 77.61% | |
72 Outperform | £1.42B | 4.19 | 14.60% | 9.91% | -28.89% | -12.14% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
67 Neutral | £118.97M | 21.20 | 1.79% | 3.29% | -9.37% | ― | |
63 Neutral | £820.44M | 2.30 | 8.81% | ― | 11.00% | ― | |
55 Neutral | ― | -5.91 | -12.49% | ― | -31.72% | -404.64% | |
50 Neutral | £477.93M | 8.09 | 7.16% | ― | ― | 33.10% |